Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
COVID-19 pandemic
|
244,616
|
7,890
|
GA
|
Top
|
2
|
Norovirus
|
214,898
|
6,932
|
B
|
Top
|
3
|
COVID-19
|
192,271
|
6,202
|
B
|
Top
|
4
|
Prion
|
133,314
|
4,300
|
GA
|
Top
|
5
|
Epstein–Barr virus
|
122,504
|
3,951
|
B
|
Top
|
6
|
Rabies
|
113,728
|
3,668
|
B
|
Top
|
7
|
HIV/AIDS
|
101,931
|
3,288
|
GA
|
Top
|
8
|
Respiratory syncytial virus
|
99,133
|
3,197
|
B
|
High
|
9
|
List of epidemics and pandemics
|
97,706
|
3,151
|
List
|
High
|
10
|
Smallpox
|
89,870
|
2,899
|
GA
|
Top
|
11
|
Human papillomavirus infection
|
82,990
|
2,677
|
B
|
Top
|
12
|
Dengue fever
|
82,727
|
2,668
|
FA
|
Top
|
13
|
Spanish flu
|
81,215
|
2,619
|
GA
|
Top
|
14
|
Shingles
|
80,249
|
2,588
|
GA
|
Top
|
15
|
Influenza A virus
|
78,401
|
2,529
|
B
|
Top
|
16
|
HIV
|
74,511
|
2,403
|
GA
|
Top
|
17
|
Virus
|
70,263
|
2,266
|
FA
|
Top
|
18
|
Molluscum contagiosum
|
68,796
|
2,219
|
B
|
High
|
19
|
Canine parvovirus
|
67,105
|
2,164
|
B
|
Top
|
20
|
Bell's palsy
|
62,362
|
2,011
|
B
|
Top
|
21
|
Rhinovirus
|
60,976
|
1,966
|
C
|
High
|
22
|
Hand, foot, and mouth disease
|
59,478
|
1,918
|
B
|
High
|
23
|
Creutzfeldt–Jakob disease
|
58,171
|
1,876
|
B
|
Top
|
24
|
Herpes simplex virus
|
57,106
|
1,842
|
B
|
Top
|
25
|
Measles
|
57,022
|
1,839
|
B
|
Top
|
26
|
Hodgkin lymphoma
|
56,367
|
1,818
|
B
|
Top
|
27
|
Chickenpox
|
55,432
|
1,788
|
B
|
Top
|
28
|
Polio
|
53,279
|
1,718
|
FA
|
Top
|
29
|
Infectious mononucleosis
|
53,258
|
1,718
|
B
|
Top
|
30
|
COVID-19 vaccine
|
52,499
|
1,693
|
B
|
Top
|
31
|
Rotavirus
|
51,850
|
1,672
|
FA
|
Top
|
32
|
Gastroenteritis
|
50,443
|
1,627
|
GA
|
Top
|
33
|
Herpes
|
49,246
|
1,588
|
GA
|
Top
|
34
|
Vaccine
|
48,071
|
1,550
|
B
|
Top
|
35
|
Hepatitis C
|
44,504
|
1,435
|
GA
|
Top
|
36
|
Bacteriophage
|
40,917
|
1,319
|
B
|
Top
|
37
|
Rosalind Franklin
|
40,786
|
1,315
|
B
|
High
|
38
|
Cytomegalovirus
|
40,381
|
1,302
|
B
|
Top
|
39
|
SARS-CoV-2
|
39,200
|
1,264
|
B
|
Top
|
40
|
Influenza
|
38,948
|
1,256
|
FA
|
High
|
41
|
List of COVID-19 vaccine authorizations
|
37,261
|
1,201
|
List
|
Mid
|
42
|
Ebola
|
36,526
|
1,178
|
B
|
Top
|
43
|
Human metapneumovirus
|
35,878
|
1,157
|
C
|
High
|
44
|
Variant Creutzfeldt–Jakob disease
|
35,734
|
1,152
|
B
|
High
|
45
|
COVID-19 lockdown in India
|
35,308
|
1,138
|
B
|
Mid
|
46
|
COVID-19 pandemic in the United States
|
35,161
|
1,134
|
B
|
Low
|
47
|
Mumps
|
35,148
|
1,133
|
B
|
Top
|
48
|
Canine distemper
|
32,691
|
1,054
|
B
|
Top
|
49
|
West Nile virus
|
32,634
|
1,052
|
B
|
High
|
50
|
Chronic wasting disease
|
32,304
|
1,042
|
C
|
Top
|
51
|
Coronavirus
|
31,236
|
1,007
|
C
|
High
|
52
|
Timeline of the COVID-19 pandemic
|
31,041
|
1,001
|
List
|
Top
|
53
|
HPV vaccine
|
30,358
|
979
|
B
|
High
|
54
|
Yellow fever
|
30,241
|
975
|
B
|
Top
|
55
|
Influenza A virus subtype H5N1
|
30,165
|
973
|
B
|
Top
|
56
|
Hepatitis B
|
30,044
|
969
|
GA
|
Top
|
57
|
COVID-19 pandemic on cruise ships
|
29,355
|
946
|
B
|
High
|
58
|
Croup
|
29,106
|
938
|
GA
|
Top
|
59
|
History of HIV/AIDS
|
28,839
|
930
|
B
|
Top
|
60
|
Varicella zoster virus
|
28,630
|
923
|
C
|
High
|
61
|
Adenoviridae
|
26,955
|
869
|
B
|
High
|
62
|
Common cold
|
25,129
|
810
|
GA
|
Top
|
63
|
Rubella
|
24,659
|
795
|
B
|
Top
|
64
|
Pandemic
|
23,898
|
770
|
B
|
High
|
65
|
HeLa
|
23,508
|
758
|
C
|
Mid
|
66
|
Kaposi's sarcoma
|
23,244
|
749
|
C
|
Mid
|
67
|
Avian influenza
|
22,466
|
724
|
B
|
High
|
68
|
Edward Jenner
|
22,332
|
720
|
B
|
High
|
69
|
COVID-19 pandemic in India
|
21,575
|
695
|
B
|
High
|
70
|
Genital wart
|
21,491
|
693
|
B
|
Top
|
71
|
COVID-19 lockdowns
|
20,767
|
669
|
B
|
Low
|
72
|
Influenza B virus
|
20,583
|
663
|
C
|
High
|
73
|
COVID-19 pandemic by country and territory
|
20,426
|
658
|
List
|
Top
|
74
|
2009 swine flu pandemic
|
20,106
|
648
|
GA
|
High
|
75
|
Messenger RNA
|
19,942
|
643
|
C
|
High
|
76
|
Foot-and-mouth disease
|
19,631
|
633
|
B
|
High
|
77
|
COVID-19 vaccination in India
|
19,489
|
628
|
C
|
Low
|
78
|
Smallpox vaccine
|
19,401
|
625
|
B
|
Mid
|
79
|
Parvovirus B19
|
19,312
|
622
|
C
|
Mid
|
80
|
Epidemiology of HIV/AIDS
|
19,209
|
619
|
C
|
High
|
81
|
SARS
|
18,570
|
599
|
C
|
Top
|
82
|
Cervical cancer
|
18,553
|
598
|
B
|
High
|
83
|
COVID-19 lab leak theory
|
18,397
|
593
|
C
|
Low
|
84
|
Feline leukemia virus
|
18,294
|
590
|
C
|
High
|
85
|
Cold sore
|
18,132
|
584
|
C
|
Top
|
86
|
SARS-CoV-2 Omicron variant
|
18,078
|
583
|
C
|
High
|
87
|
Human parainfluenza viruses
|
17,431
|
562
|
C
|
Mid
|
88
|
Influenza A virus subtype H1N1
|
17,216
|
555
|
C
|
Top
|
89
|
Enterovirus
|
17,049
|
549
|
C
|
High
|
90
|
Genital herpes
|
16,864
|
544
|
C
|
High
|
91
|
West Nile fever
|
16,815
|
542
|
C
|
High
|
92
|
Coxsackievirus
|
16,789
|
541
|
C
|
High
|
93
|
Origin of COVID-19
|
16,729
|
539
|
Start
|
Mid
|
94
|
Amantadine
|
16,701
|
538
|
C
|
High
|
95
|
Marburg virus
|
16,530
|
533
|
C
|
High
|
96
|
Orthohantavirus
|
16,438
|
530
|
B
|
Top
|
97
|
Hepatitis A
|
16,215
|
523
|
B
|
Top
|
98
|
List of deaths due to COVID-19
|
15,741
|
507
|
List
|
High
|
99
|
Retrovirus
|
15,509
|
500
|
C
|
Top
|
100
|
Chikungunya
|
15,183
|
489
|
B
|
High
|
101
|
Mpox
|
15,114
|
487
|
C
|
High
|
102
|
Interferon
|
15,112
|
487
|
B
|
Top
|
103
|
Antiviral drug
|
14,933
|
481
|
C
|
Top
|
104
|
COVID-19 pandemic deaths
|
14,825
|
478
|
C
|
Low
|
105
|
Gain-of-function research
|
14,776
|
476
|
Start
|
High
|
106
|
COVID-19 misinformation
|
14,683
|
473
|
C
|
Low
|
107
|
Sapovirus
|
14,438
|
465
|
C
|
High
|
108
|
2002–2004 SARS outbreak
|
13,587
|
438
|
B
|
Mid
|
109
|
Varicella vaccine
|
13,442
|
433
|
B
|
Top
|
110
|
Zika virus
|
13,393
|
432
|
B
|
Top
|
111
|
HIV/AIDS in the United States
|
13,338
|
430
|
C
|
Low
|
112
|
Feline immunodeficiency virus
|
13,171
|
424
|
C
|
High
|
113
|
Roseola
|
13,118
|
423
|
C
|
High
|
114
|
Remdesivir
|
12,856
|
414
|
C
|
High
|
115
|
Vaccination
|
12,795
|
412
|
B
|
Top
|
116
|
Moderna
|
12,680
|
409
|
C
|
Low
|
117
|
Herpesviridae
|
12,529
|
404
|
C
|
Top
|
118
|
Rabies virus
|
12,123
|
391
|
C
|
Top
|
119
|
Marburg virus disease
|
11,802
|
380
|
C
|
High
|
120
|
Tick-borne encephalitis
|
11,560
|
372
|
Start
|
Low
|
121
|
Zidovudine
|
11,407
|
367
|
B
|
High
|
122
|
Variants of SARS-CoV-2
|
11,402
|
367
|
C
|
Mid
|
123
|
Operation Warp Speed
|
11,270
|
363
|
C
|
High
|
124
|
Nipah virus
|
11,239
|
362
|
Start
|
Mid
|
125
|
COVID-19 pandemic in the United Kingdom
|
10,875
|
350
|
C
|
Low
|
126
|
Myxomatosis
|
10,698
|
345
|
GA
|
High
|
127
|
Dengue vaccine
|
10,611
|
342
|
C
|
Low
|
128
|
DNA polymerase
|
10,545
|
340
|
C
|
Top
|
129
|
Virus classification
|
10,541
|
340
|
C
|
Top
|
130
|
RNA interference
|
10,476
|
337
|
FA
|
High
|
131
|
Compartmental models in epidemiology
|
10,416
|
336
|
C
|
Mid
|
132
|
Tobacco mosaic virus
|
10,178
|
328
|
C
|
High
|
133
|
Western African Ebola virus epidemic
|
10,119
|
326
|
GA
|
Mid
|
134
|
Influenza vaccine
|
9,747
|
314
|
B
|
Top
|
135
|
Pithovirus
|
9,673
|
312
|
C
|
High
|
136
|
SARS-CoV-1
|
9,632
|
310
|
C
|
High
|
137
|
Timeline of HIV/AIDS
|
9,622
|
310
|
List
|
Mid
|
138
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
9,545
|
307
|
C
|
Low
|
139
|
Peter Daszak
|
9,533
|
307
|
Start
|
Low
|
140
|
Gardasil
|
9,530
|
307
|
B
|
High
|
141
|
Poliovirus
|
9,529
|
307
|
GA
|
High
|
142
|
Index case
|
9,411
|
303
|
Start
|
Low
|
143
|
Rinderpest
|
9,410
|
303
|
B
|
High
|
144
|
Japanese encephalitis
|
9,381
|
302
|
B
|
High
|
145
|
Yellow fever vaccine
|
9,272
|
299
|
C
|
High
|
146
|
Dengue virus
|
9,212
|
297
|
B
|
Top
|
147
|
Viral disease
|
8,890
|
286
|
List
|
Top
|
148
|
COVID-19 pandemic in the Philippines
|
8,779
|
283
|
B
|
Low
|
149
|
Reverse transcriptase
|
8,771
|
282
|
B
|
Top
|
150
|
Crimean–Congo hemorrhagic fever
|
8,758
|
282
|
C
|
High
|
151
|
Respiratory syncytial virus vaccine
|
8,747
|
282
|
B
|
Mid
|
152
|
Vaccine hesitancy
|
8,419
|
271
|
B
|
High
|
153
|
Hepatitis C virus
|
8,374
|
270
|
B
|
Top
|
154
|
Human herpesvirus 6
|
8,303
|
267
|
C
|
High
|
155
|
Swine influenza
|
8,261
|
266
|
B
|
High
|
156
|
RNA polymerase
|
8,249
|
266
|
B
|
High
|
157
|
Zaire ebolavirus
|
8,188
|
264
|
C
|
Top
|
158
|
RNA virus
|
8,024
|
258
|
B
|
High
|
159
|
Host (biology)
|
7,946
|
256
|
GA
|
High
|
160
|
Rabies in animals
|
7,804
|
251
|
C
|
High
|
161
|
Parvoviridae
|
7,794
|
251
|
B
|
Mid
|
162
|
Hepatitis B virus
|
7,758
|
250
|
C
|
Top
|
163
|
SV40
|
7,755
|
250
|
C
|
Mid
|
164
|
Phage therapy
|
7,702
|
248
|
C
|
Top
|
165
|
COVID-19 pandemic in Australia
|
7,623
|
245
|
B
|
Low
|
166
|
Severe acute respiratory syndrome coronavirus 2
|
7,618
|
245
|
Redirect
|
NA
|
167
|
Bioterrorism
|
7,609
|
245
|
B
|
Low
|
168
|
Viroid
|
7,500
|
241
|
C
|
High
|
169
|
Hammer-headed bat
|
7,399
|
238
|
GA
|
Low
|
170
|
Viral hemorrhagic fever
|
7,200
|
232
|
C
|
High
|
171
|
Subtypes of HIV
|
7,033
|
226
|
C
|
High
|
172
|
Face masks during the COVID-19 pandemic
|
7,010
|
226
|
B
|
Low
|
173
|
Human T-lymphotropic virus 1
|
7,006
|
226
|
C
|
High
|
174
|
Xenophobia and racism related to the COVID-19 pandemic
|
6,965
|
224
|
List
|
Low
|
175
|
Hantavirus pulmonary syndrome
|
6,961
|
224
|
Start
|
High
|
176
|
Orthomyxoviridae
|
6,922
|
223
|
B
|
High
|
177
|
Powassan virus
|
6,909
|
222
|
C
|
Mid
|
178
|
Wuhan Institute of Virology
|
6,855
|
221
|
C
|
Mid
|
179
|
Attenuated vaccine
|
6,847
|
220
|
C
|
High
|
180
|
Carcinogenesis
|
6,799
|
219
|
B
|
Mid
|
181
|
Lysogenic cycle
|
6,775
|
218
|
C
|
High
|
182
|
Hong Kong flu
|
6,773
|
218
|
C
|
Low
|
183
|
Merkel-cell carcinoma
|
6,749
|
217
|
C
|
Mid
|
184
|
COVID-19 pandemic in Singapore
|
6,747
|
217
|
B
|
High
|
185
|
Lady Mary Wortley Montagu
|
6,693
|
215
|
B
|
Low
|
186
|
Feline infectious peritonitis
|
6,665
|
215
|
C
|
High
|
187
|
Virology
|
6,611
|
213
|
B
|
Top
|
188
|
Adeno-associated virus
|
6,590
|
212
|
B
|
High
|
189
|
2020–2024 H5N1 outbreak
|
6,582
|
212
|
C
|
Low
|
190
|
Lyssavirus
|
6,575
|
212
|
C
|
Mid
|
191
|
Great Barrington Declaration
|
6,564
|
211
|
B
|
Low
|
192
|
COVID-19 pandemic in mainland China
|
6,563
|
211
|
C
|
High
|
193
|
Shope papilloma virus
|
6,538
|
210
|
C
|
Mid
|
194
|
Transduction (genetics)
|
6,506
|
209
|
C
|
High
|
195
|
Lambda phage
|
6,504
|
209
|
B
|
High
|
196
|
Baltimore classification
|
6,361
|
205
|
B
|
Top
|
197
|
Henipavirus
|
6,357
|
205
|
C
|
High
|
198
|
MERS
|
6,343
|
204
|
B
|
High
|
199
|
Polio eradication
|
6,316
|
203
|
B
|
Mid
|
200
|
Feline calicivirus
|
6,311
|
203
|
C
|
Top
|
201
|
Disease X
|
6,285
|
202
|
GA
|
Low
|
202
|
Lentivirus
|
6,220
|
200
|
C
|
Mid
|
203
|
1976 Zaire Ebola virus outbreak
|
6,212
|
200
|
C
|
Low
|
204
|
Impact of the COVID-19 pandemic on cinema
|
6,183
|
199
|
B
|
Low
|
205
|
2001 United Kingdom foot-and-mouth outbreak
|
6,106
|
196
|
C
|
Mid
|
206
|
2022–2023 mpox outbreak
|
6,071
|
195
|
B
|
Mid
|
207
|
History of COVID-19 vaccine development
|
6,054
|
195
|
C
|
Low
|
208
|
Malaysian movement control order
|
6,039
|
194
|
B
|
Low
|
209
|
Subacute sclerosing panencephalitis
|
6,036
|
194
|
C
|
Mid
|
210
|
Rubella virus
|
6,022
|
194
|
C
|
High
|
211
|
Metagenomics
|
5,941
|
191
|
GA
|
High
|
212
|
Oncovirus
|
5,912
|
190
|
C
|
Top
|
213
|
DNA virus
|
5,890
|
190
|
C
|
Top
|
214
|
Measles vaccine
|
5,800
|
187
|
C
|
Low
|
215
|
Virulence
|
5,776
|
186
|
C
|
High
|
216
|
COVID-19 pandemic in New Zealand
|
5,769
|
186
|
C
|
Low
|
217
|
Cowpox
|
5,749
|
185
|
C
|
Mid
|
218
|
Viral envelope
|
5,733
|
184
|
Start
|
Top
|
219
|
Capsid
|
5,721
|
184
|
C
|
Top
|
220
|
Travel during the COVID-19 pandemic
|
5,714
|
184
|
C
|
Low
|
221
|
List of films impacted by the COVID-19 pandemic
|
5,642
|
182
|
List
|
Mid
|
222
|
Variolation
|
5,634
|
181
|
C
|
High
|
223
|
Impact of the COVID-19 pandemic on education
|
5,615
|
181
|
C
|
Low
|
224
|
Human polyomavirus 2
|
5,575
|
179
|
C
|
High
|
225
|
COVID-19 pandemic in Victoria
|
5,572
|
179
|
C
|
Low
|
226
|
Rotavirus vaccine
|
5,567
|
179
|
C
|
High
|
227
|
Hepatitis E
|
5,542
|
178
|
GA
|
High
|
228
|
Influenza pandemic
|
5,484
|
176
|
B
|
Top
|
229
|
Hershey–Chase experiment
|
5,475
|
176
|
C
|
Mid
|
230
|
Papillomaviridae
|
5,468
|
176
|
B
|
Top
|
231
|
History of smallpox
|
5,443
|
175
|
C
|
Mid
|
232
|
Herpes simplex encephalitis
|
5,428
|
175
|
Start
|
Low
|
233
|
Poxviridae
|
5,310
|
171
|
C
|
High
|
234
|
Viral encephalitis
|
5,303
|
171
|
B
|
High
|
235
|
BK virus
|
5,286
|
170
|
B
|
Low
|
236
|
Flavivirus
|
5,283
|
170
|
B
|
High
|
237
|
Lytic cycle
|
5,174
|
166
|
C
|
High
|
238
|
Incertae sedis
|
5,155
|
166
|
C
|
Low
|
239
|
Viral hepatitis
|
5,087
|
164
|
C
|
High
|
240
|
Escherichia virus T4
|
5,087
|
164
|
Start
|
Mid
|
241
|
Viral replication
|
5,007
|
161
|
C
|
Top
|
242
|
Viral vector vaccine
|
4,986
|
160
|
Start
|
Low
|
243
|
Phage display
|
4,961
|
160
|
C
|
Mid
|
244
|
SARS-CoV-2 Delta variant
|
4,923
|
158
|
C
|
Mid
|
245
|
Picornavirus
|
4,894
|
157
|
B
|
Mid
|
246
|
Simian immunodeficiency virus
|
4,877
|
157
|
C
|
High
|
247
|
Ebolavirus
|
4,872
|
157
|
C
|
Mid
|
248
|
Hepatitis D
|
4,848
|
156
|
C
|
Mid
|
249
|
COVID-19 pandemic in Canada
|
4,835
|
155
|
B
|
Mid
|
250
|
COVID-19 pandemic in Italy
|
4,828
|
155
|
C
|
Mid
|
251
|
Lassa fever
|
4,791
|
154
|
C
|
High
|
252
|
Measles morbillivirus
|
4,748
|
153
|
C
|
Top
|
253
|
MERS-related coronavirus
|
4,743
|
153
|
B
|
High
|
254
|
COVID-19 pandemic in Germany
|
4,742
|
152
|
C
|
Low
|
255
|
COVID-19 pandemic in Europe
|
4,735
|
152
|
C
|
Low
|
256
|
Sense (molecular biology)
|
4,687
|
151
|
C
|
High
|
257
|
Kaposi's sarcoma-associated herpesvirus
|
4,682
|
151
|
C
|
High
|
258
|
H5N1 vaccine
|
4,643
|
149
|
C
|
Low
|
259
|
Molnupiravir
|
4,640
|
149
|
C
|
Mid
|
260
|
Timeline of the COVID-19 pandemic in 2019
|
4,639
|
149
|
List
|
High
|
261
|
HBsAg
|
4,632
|
149
|
Start
|
High
|
262
|
Positive-strand RNA virus
|
4,574
|
147
|
C
|
High
|
263
|
Endogenous retrovirus
|
4,561
|
147
|
C
|
Mid
|
264
|
Walter Reed
|
4,559
|
147
|
C
|
Low
|
265
|
Adenovirus infection
|
4,556
|
146
|
Start
|
Mid
|
266
|
GS-441524
|
4,516
|
145
|
Start
|
Low
|
267
|
Pandemic H1N1/09 virus
|
4,511
|
145
|
C
|
Mid
|
268
|
COVID-19 vaccine misinformation and hesitancy
|
4,509
|
145
|
B
|
Top
|
269
|
COVID-19 vaccination in the United States
|
4,483
|
144
|
Start
|
Low
|
270
|
1889–1890 pandemic
|
4,477
|
144
|
C
|
Mid
|
271
|
African swine fever virus
|
4,451
|
143
|
C
|
High
|
272
|
Spike protein
|
4,451
|
143
|
Start
|
Low
|
273
|
RNA-dependent RNA polymerase
|
4,439
|
143
|
C
|
Top
|
274
|
Human mortality from H5N1
|
4,424
|
142
|
C
|
High
|
275
|
Economic impact of the COVID-19 pandemic
|
4,418
|
142
|
B
|
Low
|
276
|
Viral cardiomyopathy
|
4,369
|
140
|
Stub
|
High
|
277
|
Zika fever
|
4,350
|
140
|
B
|
High
|
278
|
COVID-19 pandemic in the Republic of Ireland
|
4,348
|
140
|
C
|
Low
|
279
|
Bluetongue disease
|
4,269
|
137
|
B
|
High
|
280
|
COVID-19 pandemic in New South Wales
|
4,253
|
137
|
B
|
Low
|
281
|
Cache Valley orthobunyavirus
|
4,224
|
136
|
C
|
Low
|
282
|
Rhabdoviridae
|
4,204
|
135
|
C
|
High
|
283
|
Strain (biology)
|
4,190
|
135
|
C
|
High
|
284
|
Echovirus
|
4,172
|
134
|
List
|
Mid
|
285
|
Non-cellular life
|
4,146
|
133
|
Start
|
Low
|
286
|
B virus
|
4,078
|
131
|
C
|
Mid
|
287
|
Negative-strand RNA virus
|
4,077
|
131
|
B
|
Mid
|
288
|
COVID-19 pandemic in North Korea
|
4,076
|
131
|
B
|
Mid
|
289
|
HIV vaccine development
|
4,058
|
130
|
C
|
Mid
|
290
|
Coronavirus spike protein
|
4,008
|
129
|
Start
|
Low
|
291
|
1978 smallpox outbreak in the United Kingdom
|
3,999
|
129
|
B
|
Low
|
292
|
Paramyxoviridae
|
3,986
|
128
|
C
|
High
|
293
|
Arbovirus
|
3,932
|
126
|
C
|
Top
|
294
|
Giant virus
|
3,891
|
125
|
C
|
High
|
295
|
COVID-19 pandemic in Hubei
|
3,884
|
125
|
C
|
Mid
|
296
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
3,879
|
125
|
C
|
Mid
|
297
|
Global spread of H5N1
|
3,861
|
124
|
B
|
High
|
298
|
1957–1958 influenza pandemic
|
3,853
|
124
|
C
|
Mid
|
299
|
Monkeypox virus
|
3,848
|
124
|
C
|
Mid
|
300
|
Ebola virus cases in the United States
|
3,824
|
123
|
C
|
High
|
301
|
Human alphaherpesvirus 1
|
3,820
|
123
|
Start
|
Mid
|
302
|
Solid lipid nanoparticle
|
3,810
|
122
|
C
|
Low
|
303
|
1977 Russian flu
|
3,804
|
122
|
C
|
Mid
|
304
|
Vaccinia
|
3,800
|
122
|
C
|
High
|
305
|
Inclusion bodies
|
3,791
|
122
|
C
|
High
|
306
|
Diagnosis of HIV/AIDS
|
3,698
|
119
|
B
|
High
|
307
|
1793 Philadelphia yellow fever epidemic
|
3,696
|
119
|
C
|
Low
|
308
|
Feline coronavirus
|
3,692
|
119
|
C
|
Mid
|
309
|
Symptoms of COVID-19
|
3,663
|
118
|
C
|
Low
|
310
|
Australian bat lyssavirus
|
3,639
|
117
|
C
|
Low
|
311
|
Structure and genome of HIV
|
3,635
|
117
|
B
|
High
|
312
|
Oropouche fever
|
3,625
|
116
|
C
|
Low
|
313
|
List of Ebola outbreaks
|
3,615
|
116
|
List
|
Low
|
314
|
COVID-19 testing
|
3,601
|
116
|
B
|
Low
|
315
|
Marek's disease
|
3,595
|
115
|
C
|
Mid
|
316
|
Astrovirus
|
3,575
|
115
|
B
|
Low
|
317
|
Rolling circle replication
|
3,551
|
114
|
C
|
Mid
|
318
|
DNA vaccine
|
3,531
|
113
|
Start
|
Low
|
319
|
Nipah virus infection
|
3,519
|
113
|
C
|
High
|
320
|
Orthopoxvirus
|
3,515
|
113
|
C
|
High
|
321
|
Ebola vaccine
|
3,505
|
113
|
C
|
Mid
|
322
|
Koplik's spots
|
3,503
|
113
|
C
|
Mid
|
323
|
Human alphaherpesvirus 2
|
3,499
|
112
|
Start
|
Mid
|
324
|
COVID-19 pandemic in Japan
|
3,446
|
111
|
C
|
Low
|
325
|
Zhang Yongzhen
|
3,435
|
110
|
Start
|
Low
|
326
|
Obelisk (biology)
|
3,429
|
110
|
Unknown
|
High
|
327
|
History of virology
|
3,420
|
110
|
B
|
Top
|
328
|
COVID-19 lockdown in China
|
3,404
|
109
|
C
|
High
|
329
|
HIV trial in Libya
|
3,395
|
109
|
B
|
Low
|
330
|
Plant virus
|
3,392
|
109
|
C
|
Top
|
331
|
Mumps virus
|
3,389
|
109
|
B
|
High
|
332
|
Spillover infection
|
3,385
|
109
|
Start
|
Mid
|
333
|
COVID-19 pandemic in Maharashtra
|
3,300
|
106
|
C
|
Low
|
334
|
Conjugate vaccine
|
3,278
|
105
|
C
|
High
|
335
|
Natural reservoir
|
3,270
|
105
|
C
|
High
|
336
|
Ivermectin during the COVID-19 pandemic
|
3,266
|
105
|
B
|
Low
|
337
|
List of diseases of the honey bee
|
3,255
|
105
|
List
|
High
|
338
|
COVID-19 pandemic in South Africa
|
3,253
|
104
|
B
|
Mid
|
339
|
Timeline of the COVID-19 pandemic in Canada
|
3,242
|
104
|
B
|
Mid
|
340
|
Impact of the COVID-19 pandemic on the environment
|
3,204
|
103
|
C
|
Low
|
341
|
COVID-19 pandemic in Malaysia
|
3,199
|
103
|
B
|
High
|
342
|
Congenital rubella syndrome
|
3,193
|
103
|
Start
|
Mid
|
343
|
Impact of the COVID-19 pandemic on commercial air transport
|
3,152
|
101
|
C
|
Low
|
344
|
Timeline of the COVID-19 pandemic in England (2022)
|
3,121
|
100
|
List
|
Low
|
345
|
Tomato yellow leaf curl virus
|
3,110
|
100
|
C
|
Low
|
346
|
Molluscum contagiosum virus
|
3,089
|
99
|
C
|
Mid
|
347
|
Virulent Newcastle disease
|
3,059
|
98
|
C
|
High
|
348
|
Human coronavirus OC43
|
3,045
|
98
|
C
|
Mid
|
349
|
SARS-CoV-2 Alpha variant
|
3,039
|
98
|
C
|
Low
|
350
|
COVID-19 pandemic in New York City
|
3,037
|
97
|
Start
|
Low
|
351
|
Metapneumovirus
|
2,998
|
96
|
Stub
|
Mid
|
352
|
Viral evolution
|
2,995
|
96
|
C
|
High
|
353
|
Human betaherpesvirus 5
|
2,991
|
96
|
C
|
High
|
354
|
Viral shedding
|
2,973
|
95
|
Start
|
High
|
355
|
Antibody-dependent enhancement
|
2,943
|
94
|
C
|
High
|
356
|
COVID-19 pandemic on Diamond Princess
|
2,930
|
94
|
Start
|
Low
|
357
|
Coxsackie B virus
|
2,927
|
94
|
C
|
Mid
|
358
|
Oropouche orthobunyavirus
|
2,906
|
93
|
Start
|
Mid
|
359
|
Impact of the COVID-19 pandemic on the video game industry
|
2,901
|
93
|
C
|
Low
|
360
|
Intracellular parasite
|
2,893
|
93
|
Start
|
Mid
|
361
|
Heterophile antibody test
|
2,891
|
93
|
C
|
Low
|
362
|
Pleomorphism (microbiology)
|
2,870
|
92
|
C
|
High
|
363
|
Flat wart
|
2,855
|
92
|
Stub
|
Mid
|
364
|
Hendra virus
|
2,830
|
91
|
Start
|
Mid
|
365
|
Emerging infectious disease
|
2,828
|
91
|
Start
|
Low
|
366
|
Influenza A virus subtype H3N2
|
2,824
|
91
|
C
|
High
|
367
|
Filoviridae
|
2,812
|
90
|
Start
|
High
|
368
|
Viral pneumonia
|
2,812
|
90
|
Start
|
High
|
369
|
Virus latency
|
2,799
|
90
|
C
|
High
|
370
|
Primate T-lymphotropic virus
|
2,790
|
90
|
C
|
High
|
371
|
Pod People (Invasion of the Body Snatchers)
|
2,762
|
89
|
Start
|
Low
|
372
|
List of biosafety level 4 organisms
|
2,753
|
88
|
List
|
Low
|
373
|
Ebola virus
|
2,744
|
88
|
Redirect
|
NA
|
374
|
PEGylation
|
2,741
|
88
|
C
|
Low
|
375
|
COVID-19 pandemic in Sweden
|
2,739
|
88
|
B
|
Low
|
376
|
White House Coronavirus Task Force
|
2,730
|
88
|
C
|
Low
|
377
|
COVID-19 pandemic in Russia
|
2,721
|
87
|
C
|
Low
|
378
|
Caliciviridae
|
2,720
|
87
|
C
|
Mid
|
379
|
COVID-19 pandemic in Tamil Nadu
|
2,719
|
87
|
C
|
Low
|
380
|
Vertically transmitted infection
|
2,712
|
87
|
C
|
High
|
381
|
Polyomaviridae
|
2,709
|
87
|
C
|
High
|
382
|
SARS-related coronavirus
|
2,708
|
87
|
C
|
High
|
383
|
Impact of the COVID-19 pandemic on sports
|
2,705
|
87
|
C
|
Mid
|
384
|
Riboviria
|
2,703
|
87
|
B
|
Top
|
385
|
Lamivudine
|
2,699
|
87
|
C
|
Mid
|
386
|
Vaccine shedding
|
2,690
|
86
|
Start
|
Mid
|
387
|
Jonathan Van-Tam
|
2,690
|
86
|
C
|
Low
|
388
|
Eastern equine encephalitis
|
2,686
|
86
|
C
|
Mid
|
389
|
Mimivirus
|
2,684
|
86
|
C
|
Mid
|
390
|
2020–21 Singapore circuit breaker measures
|
2,661
|
85
|
C
|
Low
|
391
|
Edible vaccine
|
2,653
|
85
|
C
|
Low
|
392
|
Enhanced community quarantine in Luzon
|
2,639
|
85
|
B
|
Low
|
393
|
List of unproven methods against COVID-19
|
2,636
|
85
|
List
|
Mid
|
394
|
Carnivore protoparvovirus 1
|
2,632
|
84
|
Start
|
Mid
|
395
|
Timeline of the COVID-19 pandemic in January 2020
|
2,628
|
84
|
List
|
High
|
396
|
Reverse-transcriptase inhibitor
|
2,620
|
84
|
C
|
High
|
397
|
Hantavirus hemorrhagic fever with renal syndrome
|
2,614
|
84
|
Start
|
High
|
398
|
Ross River virus
|
2,608
|
84
|
C
|
Mid
|
399
|
COVID-19 vaccination in the United Kingdom
|
2,605
|
84
|
C
|
Low
|
400
|
Bat virome
|
2,593
|
83
|
GA
|
High
|
401
|
Discrimination against people with HIV/AIDS
|
2,586
|
83
|
C
|
High
|
402
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
2,579
|
83
|
List
|
Low
|
403
|
Virgin cleansing myth
|
2,568
|
82
|
Start
|
Low
|
404
|
Borealpox virus
|
2,559
|
82
|
Start
|
Low
|
405
|
Superinfection
|
2,553
|
82
|
Stub
|
Mid
|
406
|
Deployment of COVID-19 vaccines
|
2,548
|
82
|
C
|
High
|
407
|
Jeremy Farrar
|
2,538
|
81
|
C
|
Low
|
408
|
Rift Valley fever
|
2,525
|
81
|
C
|
High
|
409
|
Timeline of human vaccines
|
2,518
|
81
|
List
|
Low
|
410
|
M13 bacteriophage
|
2,509
|
80
|
Start
|
Mid
|
411
|
Alphavirus
|
2,494
|
80
|
B
|
Mid
|
412
|
COVID-19 pandemic in South Korea
|
2,494
|
80
|
B
|
Low
|
413
|
FFP standards
|
2,486
|
80
|
C
|
Mid
|
414
|
COVID-19 pandemic in California
|
2,477
|
79
|
C
|
Mid
|
415
|
Anti-CRISPR
|
2,465
|
79
|
C
|
Mid
|
416
|
Tulip breaking virus
|
2,461
|
79
|
C
|
High
|
417
|
Baculoviridae
|
2,447
|
78
|
C
|
Mid
|
418
|
Negri body
|
2,444
|
78
|
Start
|
Mid
|
419
|
Double-stranded RNA viruses
|
2,442
|
78
|
Start
|
High
|
420
|
Oncolytic virus
|
2,437
|
78
|
B
|
Mid
|
421
|
History of coronavirus
|
2,436
|
78
|
B
|
Mid
|
422
|
Flaviviridae
|
2,427
|
78
|
Start
|
High
|
423
|
Rabbit hemorrhagic disease
|
2,427
|
78
|
B
|
Mid
|
424
|
COVID-19 vaccination mandates in the United States
|
2,388
|
77
|
Start
|
Low
|
425
|
Invertebrate iridescent virus 31
|
2,387
|
77
|
Start
|
Low
|
426
|
Innate resistance to HIV
|
2,386
|
76
|
C
|
High
|
427
|
COVID-19 pandemic in Hong Kong
|
2,386
|
76
|
C
|
Low
|
428
|
Koilocyte
|
2,379
|
76
|
Start
|
Low
|
429
|
Eczema herpeticum
|
2,356
|
76
|
Start
|
Low
|
430
|
Lassa mammarenavirus
|
2,320
|
74
|
Start
|
Mid
|
431
|
COVID-19 pandemic in Pakistan
|
2,319
|
74
|
B
|
Low
|
432
|
Timeline of the COVID-19 pandemic in March 2020
|
2,317
|
74
|
List
|
High
|
433
|
Virus-like particle
|
2,310
|
74
|
C
|
Mid
|
434
|
Kyasanur Forest disease
|
2,303
|
74
|
B
|
Mid
|
435
|
Pigeon pox
|
2,301
|
74
|
Stub
|
Low
|
436
|
Hemagglutination assay
|
2,291
|
73
|
C
|
Mid
|
437
|
Orthornavirae
|
2,291
|
73
|
B
|
High
|
438
|
Cytopathic effect
|
2,289
|
73
|
C
|
High
|
439
|
HIV/AIDS in Russia
|
2,287
|
73
|
Start
|
Low
|
440
|
Tick-borne encephalitis virus
|
2,280
|
73
|
C
|
High
|
441
|
Human betaherpesvirus 7
|
2,278
|
73
|
C
|
Mid
|
442
|
Banana bunchy top virus
|
2,268
|
73
|
C
|
Mid
|
443
|
Chinese government response to COVID-19
|
2,263
|
73
|
B
|
Mid
|
444
|
Human coronavirus NL63
|
2,255
|
72
|
C
|
Low
|
445
|
Psittacine beak and feather disease
|
2,246
|
72
|
Start
|
Mid
|
446
|
U.S. state and local government responses to the COVID-19 pandemic
|
2,233
|
72
|
C
|
Mid
|
447
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
2,230
|
71
|
List
|
Low
|
448
|
List of virus species
|
2,221
|
71
|
List
|
Top
|
449
|
COVID-19 pandemic in Kerala
|
2,201
|
71
|
C
|
Low
|
450
|
HA-tag
|
2,194
|
70
|
Start
|
High
|
451
|
COVID-19 pandemic in France
|
2,171
|
70
|
B
|
Mid
|
452
|
Sedoreoviridae
|
2,144
|
69
|
C
|
Mid
|
453
|
Bacteriophage MS2
|
2,144
|
69
|
Start
|
Mid
|
454
|
HIV/AIDS in the Philippines
|
2,137
|
68
|
Start
|
Low
|
455
|
COVID-19 pandemic in North America
|
2,134
|
68
|
C
|
Mid
|
456
|
T7 RNA polymerase
|
2,128
|
68
|
Start
|
Low
|
457
|
Phi X 174
|
2,117
|
68
|
Start
|
Mid
|
458
|
Feline spongiform encephalopathy
|
2,096
|
67
|
Start
|
Low
|
459
|
Political impact of the COVID-19 pandemic
|
2,091
|
67
|
B
|
Low
|
460
|
List of pests and diseases of roses
|
2,073
|
66
|
List
|
Mid
|
461
|
Face masks during the COVID-19 pandemic in the United States
|
2,067
|
66
|
C
|
Low
|
462
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
2,064
|
66
|
List
|
Low
|
463
|
Catholic Church and HIV/AIDS
|
2,062
|
66
|
C
|
Mid
|
464
|
COVID-19 pandemic in Indonesia
|
2,055
|
66
|
C
|
Low
|
465
|
Orf (disease)
|
2,054
|
66
|
Start
|
Low
|
466
|
COVID-19 pandemic in Bangladesh
|
2,050
|
66
|
Start
|
Mid
|
467
|
Kivu Ebola epidemic
|
2,044
|
65
|
GA
|
High
|
468
|
HIV superinfection
|
2,036
|
65
|
C
|
Mid
|
469
|
Human coronavirus 229E
|
2,023
|
65
|
Start
|
Mid
|
470
|
Arenavirus
|
2,019
|
65
|
C
|
High
|
471
|
Cervarix
|
2,015
|
65
|
C
|
Mid
|
472
|
Lentiviral vector in gene therapy
|
2,013
|
64
|
C
|
Low
|
473
|
Antigenic shift
|
2,010
|
64
|
Start
|
High
|
474
|
Coronaviridae
|
2,006
|
64
|
Start
|
High
|
475
|
Cucumber mosaic virus
|
2,001
|
64
|
C
|
Mid
|
476
|
Coxsackie A virus
|
1,990
|
64
|
Start
|
Mid
|
477
|
Nipah virus outbreaks in Kerala
|
1,967
|
63
|
C
|
Low
|
478
|
2015–16 Zika virus epidemic
|
1,961
|
63
|
B
|
Mid
|
479
|
Mosaic virus
|
1,957
|
63
|
List
|
Mid
|
480
|
Bunyavirales
|
1,955
|
63
|
C
|
Mid
|
481
|
Viral load
|
1,953
|
63
|
Start
|
Mid
|
482
|
Papaya ringspot virus
|
1,953
|
63
|
C
|
Mid
|
483
|
Pandoravirus
|
1,949
|
62
|
Start
|
High
|
484
|
Swedish government response to the COVID-19 pandemic
|
1,942
|
62
|
C
|
Low
|
485
|
COVID-19 pandemic in New York (state)
|
1,935
|
62
|
C
|
Low
|
486
|
Human bocavirus
|
1,930
|
62
|
C
|
Mid
|
487
|
White House COVID-19 outbreak
|
1,925
|
62
|
C
|
Low
|
488
|
Lymphocytic choriomeningitis
|
1,924
|
62
|
C
|
Mid
|
489
|
Fowlpox
|
1,924
|
62
|
Start
|
Low
|
490
|
Introduction to viruses
|
1,921
|
61
|
FA
|
Top
|
491
|
Reston virus
|
1,909
|
61
|
C
|
Low
|
492
|
COVID-19 pandemic in Sri Lanka
|
1,909
|
61
|
B
|
Low
|
493
|
Hemagglutinin (influenza)
|
1,903
|
61
|
C
|
High
|
494
|
British government response to the COVID-19 pandemic
|
1,901
|
61
|
C
|
Low
|
495
|
MOG antibody disease
|
1,899
|
61
|
C
|
Mid
|
496
|
Transmission of COVID-19
|
1,894
|
61
|
C
|
High
|
497
|
Salmon isavirus
|
1,879
|
60
|
Start
|
Mid
|
498
|
History of the COVID-19 pandemic in the United Kingdom
|
1,858
|
59
|
C
|
High
|
499
|
Nanoparticle drug delivery
|
1,857
|
59
|
C
|
Low
|
500
|
Black flying fox
|
1,856
|
59
|
C
|
Mid
|